The DZIF partner site in München coordinates the Gastrointestinal Infections, Hepatitis and Tuberculosis research areas. Scientists at the DZIF site in München are also involved in researching the immune control of infections, the defence against emerging infections and the development of new treatment methods. Pathogen-specific immunotherapies (e.g. vaccinations or (adoptive) T-cell transfer) aim to strengthen the body’s immune system in order to better control or completely cure specific infectious diseases. The München partner site further focuses on HIV and Biobanking.